Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2010
12/02/2010US20100300521 Squarylium dyes including an anchoring group
12/02/2010CA2763633A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763624A1 Pyrimidine inhibitors of kinase activity
12/02/2010CA2763498A1 Pyrazinylpyrazoles
12/02/2010CA2763140A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
12/02/2010CA2763130A1 Radiolabeled pde10 inhibitors
12/02/2010CA2762885A1 Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis c
12/02/2010CA2762528A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
12/01/2010EP2256113A1 Inhibitors of serine proteases
12/01/2010EP2256108A1 Substituted triazine kinase inhibitors
12/01/2010EP2256106A1 3,4-disubstituted 1H-pyrazole compounds and their use as cyclin dependent kinases (CDK) and glycogen synthase kinase-3 (GSK-3) modulators
12/01/2010EP2255801A1 Pharmaceutically active isoindoline derivatives
12/01/2010EP2254885A1 (pyrazolyl carbonyl)imidazolidinone derivatives for the treatment of retroviral diseases
12/01/2010EP2254884A2 3-alkyl-piperazine derivatives and uses thereof
12/01/2010EP2254864A1 Substituted 4-aminocyclohexane derivatives for the treatment of pain
12/01/2010EP2254580A1 Methods for treating disorders using nmda nr2b-subtype selective antagonist
12/01/2010EP2254415A1 Aryl-hydroxyethylamino-pyrimidines and triazines as modulators of fatty acid amide hydrolase
12/01/2010EP1869020B1 Heteroaryl urea derivatives useful for inhibiting chk1
12/01/2010EP1590336B1 Substituted pyrazoles, compositions containing such compounds and methods of use
12/01/2010EP1368342B3 Benzimidazole and pyridylimidazole derivatives as ligands for gaba receptors
12/01/2010CN101903391A Process for the preparation of a macrocycle
12/01/2010CN101903374A 2-benzylpyridazinone derivatives as met kinase inhibitors
12/01/2010CN101903373A Functionally selective alpha2c adrenoreceptor agonists
12/01/2010CN101903362A Tetrazole-substituted arylamide derivatives and their use as P2X3 and/or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903359A Triazole-substituted arylamide derivatives and their use as P2X3 and /or P2X2/3 purinergic receptor antagonists
12/01/2010CN101903358A Perhydrochinoxalin-derivate
12/01/2010CN101903355A Novel imidazole-substituted arylamides
12/01/2010CN101903342A Substituted N-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine H3 receptor modulators
12/01/2010CN101903341A Substituted N-phenyl-bipyrrolidine ureas and therapeutic use thereof
12/01/2010CN101903340A Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101903339A Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof
12/01/2010CN101902912A Fungicidal amines
12/01/2010CN101899038A Near-infrared light emitting ionic complex and preparation method thereof
12/01/2010CN101899037A Derivative with heteroaromatic ring, and light-emitting element, light-emitting device, lighting device, and electronic device using derivative with heteroaromatic ring
12/01/2010CN101899010A Quinazol derivative, preparation method and application thereof
12/01/2010CN101899006A 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
11/2010
11/30/2010US7842820 Sulfonylpyrroles
11/30/2010US7842816 Mitogen-activated protein kinase kinase inhibitors such as 2-amino-3-methylbutyric acid 2-{[6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H -benzoimidazole-5-carbonyl]-aminooxy}-ethylester, used for the treatment of diseases, such as cancer and inflammation in mammals
11/30/2010US7842805 1-arylamino-phthalazines such as 5-Fluorophthalazin-1-yl)-(4-methoxyphenyl)-methyl-amine or 4-arylamino-benzo[d][1,2,3]triazines such as Benzo[d][1,2,3]triazin-4-y1-(4-methoxy-pheny1)-methyl-amine, used as anticarcinogenic agents or for the treatment of psoriasis, autoimmune diseases and fungi infections
11/30/2010US7842712 Indazolinone compositions useful as kinase inhibitors
11/30/2010US7842695 such as 1-{1-[5-(4-Fluorophenyl)pyridin-2-yl]-5-furan-2-yl-1H-pyrazol-4-ylmethyl}-4-methylpiperazine, exhibiting selective serotonin receptor antagonistic properties, used for the prophylaxis and/or treatment of psychoses, neurological disorders, amyotrophic lateral sclerosis, eating and vision disorders
11/30/2010US7842693 For therapy of rheumatoid arthritis, multiple sclerosis, transplant rejection, dermnatitis, eczema, urticaria, vasculitis, inflammatory bowel disease, food allergy and encephalomyelitis
11/30/2010CA2647590C Process for production of ethylenediamine derivatives having halogenated carbamate group and acyl group, and intermediates for production of the derivatives
11/30/2010CA2624621C Pyrazine derivatives
11/30/2010CA2607499C Histamine-3 receptor antagonists
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2515151C Non-nucleoside reverse transcriptase inhibitors
11/30/2010CA2432809C Heteroaryl urea neuropeptide y y5 receptor antagonists
11/25/2010WO2010133885A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/25/2010WO2010133544A1 Piperazine and aminopyrrolidine compounds as histamine h3 receptor antagonists
11/25/2010WO2010133336A1 Insecticidal arylpyrrolines
11/25/2010WO2010132999A1 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
11/25/2010WO2010116380A3 A one pot process for preparing 2-butyl-3-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1,3-diazaspiro [4, 4] non-1-en-4-one (irbesartan)
11/25/2010WO2010106436A3 Novel anti-inflammatory agents
11/25/2010WO2010099379A8 Jak kinase modulating quinazoline derivatives and methods of use thereof
11/25/2010WO2010088050A3 Bicyclic pyrazolo-heterocycles
11/25/2010WO2010081036A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2010081034A3 Fluorine containing compounds and methods of use thereof
11/25/2010WO2010080817A3 Carbohydrate-cyclopamine conjugates as anticancer agents
11/25/2010WO2010049449A3 Novel salts of sunitinib
11/25/2010WO2009132202A3 Macrocyclic compounds and their use as kinase inhibitors
11/25/2010WO2009109991A3 Novel hydrazide containing tyrosine kinase inhibitors
11/25/2010US20100298568 Processes and intermediates for preparing steric compounds
11/25/2010US20100298565 Processes for the Preparation of Paliperidone and Pharmaceutically Acceptable Salts Thereof and Intermediates for Use in the Processes
11/25/2010US20100298381 Gamma secretase modulators
11/25/2010US20100298359 Gamma secretase modulators
11/25/2010US20100298357 Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
11/25/2010US20100298344 Polycationic Compounds And Uses Thereof
11/25/2010US20100298343 5-lipoxygenase-activating protein (flap) inhibitors
11/25/2010US20100298336 Pyrimidines as novel therapeutic agents
11/25/2010US20100298323 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/25/2010US20100298322 Quinazolines and Related Heterocyclic Compounds, and Their Therapeutic Use
11/25/2010US20100298312 Substituted pyrimidinyl-amines as protein kinase inhibitors
11/25/2010US20100298301 Oxazole tyrosine kinase inhibitors
11/25/2010US20100298299 non-peptide derivatives as bradykinin b1 antagonists
11/25/2010US20100298298 Quinazolinedione derivatives, preparation thereof and therapeutic uses thereof
11/25/2010US20100298297 Tetrahydropyridothienopyrimidine Compounds and Methods of Use Thereof
11/25/2010US20100298295 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors
11/25/2010US20100298291 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/25/2010US20100298289 Heterobicyclic compounds as histamine h4-receptor antagonists
11/25/2010US20100298267 Aminopyrimidinamides as pesticides
11/25/2010US20100298183 Additive for oils and lubricant comprising the same
11/25/2010US20100298168 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
11/25/2010US20100297405 Ketopyrroles as organic semiconductors
11/25/2010US20100297038 Benzimidazole Derivatives And Their Use As Cooling Agents
11/25/2010US20100297035 Thiazole Amides, Imidazole Amides and Related Analogues
11/25/2010US20100297009 Self-assembled polyhedral multimeric chemical structures
11/25/2010CA2760766A1 Novel pyrimidine derivatives and their use in the treatment of cancer and further diseases
11/24/2010EP2253629A1 Polymorphs of racemic sunitinib malate, compositions containing them and preparation thereof
11/24/2010EP2253618A1 Compound having 6-membered aromatic ring
11/24/2010EP2253614A1 Inhibitors of IAP
11/24/2010EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound
11/24/2010EP2253315A1 Alkoxyphenylpropanoic acid derivatives
11/24/2010EP2252608A1 Method for treating pain syndrome and other disorders
11/24/2010EP2252607A2 Novel polymorphs and processes for their preparation
11/24/2010EP2252606A1 Pyrimidylmethyl sulfonamide compounds
11/24/2010EP2252600A1 Substituted triazinylmethyl sulfonamides
11/24/2010EP2252599A1 Triazole amide derivatives for use in therapy
11/24/2010EP2252598A2 1,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11beta-hydroxysteroid dehydrogenase 1
11/24/2010EP2252597A2 Novel compounds, use and preparation thereof
1 ... 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 ... 626